companydata.dkcompanydata.dk

BIOSYNTIA ApS: Financial statements 2023

CVR: 34892970

Source: annual report 2023, Danish Business Authority

01/01/2023 – 31/12/2023

BIOSYNTIA ApS (CVR 34892970) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -17,798,034 and a net result of DKK -29,430,438 compared with DKK -26,434,976 the year before. Equity in the 2023 report amounted to DKK 71,836,048. The solvency ratio was 77.7%. The company had 19 employees in the financial year.

Gross Profit
DKK -17,798,034
Profit/Loss
DKK -29,430,438
Equity
DKK 71,836,048
Total Assets
DKK 92,459,442
Employees
19

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2023--17.8 mio.-29.4 mio.71.8 mio.19
2022--16.6 mio.-26.4 mio.101.3 mio.19
2021-1.2 mio.-10.1 mio.16.2 mio.17
2020-818 t.-9.4 mio.26.2 mio.21
2019-439 t.-8.2 mio.16.9 mio.20

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2023

BIOSYNTIA ApS: The 2022 annual report is outJun 19, 2023

BIOSYNTIA ApS has published its annual report for 2022. Gross profit came to DKK -16,583,471, and the net result was DKK -26,434,976.

Danmarks Eksport- og Investeringsfond registered as owner of BIOSYNTIA ApSApr 1, 2023

As of April 1, 2023, Danmarks Eksport- og Investeringsfond is registered as an owner of BIOSYNTIA ApS with an ownership share of 10%.

About BIOSYNTIA ApS

BIOSYNTIA ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2012. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Martin Plambech. The board consists of Henrik Dalbøge (chair), Joško Bobanović and Thomas Grotkjær. The company's owners include Novo Holdings A/S, Danmarks Eksport- og Investeringsfond and Sofinnova Industrial Biotech I. The company has 25 employees (2018). In 2025, the company reported a gross profit of DKK -14,222,601 and a net result of DKK -20,066,332 compared with DKK -18,909,140 the year before. Equity in the 2025 report amounted to DKK 32,860,576.

Source: annual report 2025, Danish Business Authority